PracticeBlogFlashcardsEspañol
All Practice Exams

299+ Free NY MPJE Practice Questions

Pass your New York Multistate Pharmacy Jurisprudence Examination exam on the first try — instant access, no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately
Not publicly reported Pass Rate
299+ Questions
100% Free
1 / 299
Question 1
Score: 0/0

Under the Controlled Substances Act (CSA), which DEA schedule includes drugs with the highest potential for abuse and no currently accepted medical use?

A
B
C
D
to track
2026 Statistics

Key Facts: NY MPJE Exam

120

Exam Questions

100 scored + 20 pretest

75

Passing Score

Scaled score

2.5 hrs

Time Limit

NABP

45

CE Hours

Per renewal period

7-day supply

Initial Opioid Limit

New York acute pain

1,500 hours

Intern Hours Required

NY Board

The NY MPJE covers federal pharmacy law (DEA, FDA, CSA, HIPAA) and New York-specific regulations including I-STOP (Internet System for Tracking Over-Prescribing), 45 CE hours per triennial renewal, shared pharmacy services law (effective May 2026), pharmacist immunization authority, and naloxone access under standing orders. The NYSED Office of the Professions regulates pharmacy in New York.

Sample NY MPJE Practice Questions

Try these sample questions to test your NY MPJE exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 299+ question experience with AI tutoring.

1Under the Controlled Substances Act (CSA), which DEA schedule includes drugs with the highest potential for abuse and no currently accepted medical use?
A.Schedule I
B.Schedule II
C.Schedule III
D.Schedule IV
Explanation: Schedule I substances have a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision. Examples include heroin, LSD, and MDMA. Pharmacists cannot dispense Schedule I substances under normal practice.
2A DEA Form 222 is required for the transfer of which schedule of controlled substances between registrants?
A.Schedule II only
B.Schedules II and III
C.Schedules III through V
D.All controlled substances
Explanation: DEA Form 222 (or its electronic equivalent under CSOS) is required for the distribution and transfer of Schedule II controlled substances between DEA registrants. Schedules III-V can be transferred using invoices with specific record-keeping requirements.
3Under federal law, what is the maximum number of refills allowed for a Schedule III controlled substance prescription?
A.No refills allowed
B.Up to 3 refills within 6 months
C.Up to 5 refills within 6 months
D.Up to 5 refills within 1 year
Explanation: Federal law allows up to 5 refills for Schedule III-V controlled substance prescriptions within 6 months from the date the prescription was issued. Schedule II prescriptions cannot be refilled. After 6 months or 5 refills, a new prescription is required.
4The Durham-Humphrey Amendment of 1951 established which key distinction in drug classification?
A.Generic vs. brand-name drugs
B.Prescription (legend) vs. over-the-counter drugs
C.Controlled vs. non-controlled substances
D.Biological vs. chemical drugs
Explanation: The Durham-Humphrey Amendment to the Federal Food, Drug, and Cosmetic Act (FDCA) established the distinction between prescription (legend) drugs and over-the-counter (OTC) drugs. It required that certain drugs be dispensed only with a valid prescription and bear the legend 'Caution: Federal law prohibits dispensing without prescription.'
5Under the Poison Prevention Packaging Act (PPPA), which of the following medications is EXEMPT from child-resistant packaging requirements?
A.Acetaminophen tablets
B.Sublingual nitroglycerin tablets
C.Amoxicillin suspension
D.Hydrocodone/acetaminophen tablets
Explanation: Sublingual nitroglycerin tablets are exempt from child-resistant packaging under the PPPA because they require immediate access during cardiac emergencies. Other exemptions include oral contraceptives in manufacturer dispensing packages, certain hormone replacement therapy, and isosorbide dinitrate sublingual tablets.
6What is the primary purpose of the FDA's Risk Evaluation and Mitigation Strategies (REMS) program?
A.To reduce drug manufacturing costs
B.To ensure the benefits of a drug outweigh its risks
C.To speed up the drug approval process
D.To establish drug pricing guidelines
Explanation: REMS are drug safety programs required by the FDA for certain medications with serious safety concerns. They help ensure the benefits of a medication outweigh its risks. REMS may include medication guides, communication plans, and Elements to Assure Safe Use (ETASU) such as prescriber certification and patient registries.
7Under the Combat Methamphetamine Epidemic Act (CMEA), what is the maximum amount of pseudoephedrine a customer can purchase in a 30-day period?
A.3.6 grams
B.7.5 grams
C.9 grams
D.15 grams
Explanation: The CMEA limits pseudoephedrine purchases to 3.6 grams per day and 9 grams per 30-day period for retail transactions. Mail-order purchases are limited to 7.5 grams per 30-day period. Retailers must keep a logbook of all pseudoephedrine sales and products must be kept behind the counter.
8A pharmacist receives a prescription for a Schedule II controlled substance dated 45 days ago. Under federal law, this prescription:
A.Must be filled within 30 days
B.May be filled as there is no federal time limit
C.Cannot be filled because it has expired
D.May only be partially filled
Explanation: Federal law does not impose a specific time limit on filling Schedule II prescriptions. However, many states, including New Jersey, may impose their own time limits. The pharmacist must use professional judgment to determine whether the prescription is still valid based on the patient's needs and state law requirements.
9Under the Health Insurance Portability and Accountability Act (HIPAA), which of the following is NOT considered protected health information (PHI)?
A.A patient's prescription history
B.A patient's date of birth
C.De-identified aggregate prescription data
D.A patient's home address
Explanation: De-identified data is not considered PHI under HIPAA. PHI includes individually identifiable health information such as names, dates, addresses, Social Security numbers, and medical records. Data that has been properly de-identified according to HIPAA standards (Safe Harbor or Expert Determination method) is not subject to HIPAA restrictions.
10Under the Drug Supply Chain Security Act (DSCSA), what must be included with each transaction of a prescription drug between trading partners?
A.Only the drug name and NDC number
B.Transaction information, transaction history, and transaction statement
C.DEA Form 222 and invoice
D.Certificate of analysis and lot number only
Explanation: The DSCSA requires three types of documentation for each prescription drug transaction: transaction information (drug details, date, entities involved), transaction history (previous ownership chain), and transaction statement (attestation that the trading partner meets DSCSA requirements). This supports drug supply chain integrity and helps prevent counterfeit drugs.

About the NY MPJE Exam

The NY MPJE tests knowledge of federal pharmacy law and New York-specific pharmacy regulations. Required alongside the NAPLEX for pharmacist licensure in New York.

Questions

120 scored questions

Time Limit

2.5 hours

Passing Score

75 (scaled score)

Exam Fee

$250 (NABP / New York State Education Department (NYSED) Office of the Professions)

NY MPJE Exam Content Outline

22%

Licensure & Personnel

Pharmacist qualifications, intern/technician requirements, license renewal, disciplinary actions

33%

Pharmacist Practice

Prescription requirements, counseling, collaborative practice, immunizations

24%

Dispensing Requirements

Generic substitution, prescription transfers, DUR, labeling, I-STOP compliance

21%

Pharmacy Operations

Controlled substance records, compounding, pharmacy permits, automated dispensing

How to Pass the NY MPJE Exam

What You Need to Know

  • Passing score: 75 (scaled score)
  • Exam length: 120 questions
  • Time limit: 2.5 hours
  • Exam fee: $250

Keys to Passing

  • Complete 500+ practice questions
  • Score 80%+ consistently before scheduling
  • Focus on highest-weighted sections
  • Use our AI tutor for tough concepts

NY MPJE Study Tips from Top Performers

1Master Article 137 of the Education Law and Title 8 NYCRR and New York pharmacy regulations
2Know I-STOP (Internet System for Tracking Over-Prescribing) requirements for controlled substance dispensing
3Study New York CE requirements: 45 contact hours per triennial (3-year) renewal with 3 hours of pharmacy law and 2 hours of child abuse recognition
4Understand New York pharmacist-to-technician ratios: 1:2
5Review New York opioid prescribing limits: 7-day supply

Frequently Asked Questions

What is the NY MPJE exam format?

The NY MPJE is a computer-adaptive test with 120 questions (100 scored, 20 pretest). You have 2.5 hours. A scaled score of 75 or higher is required to pass.

What New York-specific topics are tested?

Key topics include Article 137 of the Education Law and Title 8 NYCRR, the I-STOP (Internet System for Tracking Over-Prescribing), 45 contact hours per triennial (3-year) renewal with 3 hours of pharmacy law and 2 hours of child abuse recognition, 7-day supply initial opioid limit, pharmacist immunization authority for patients 18+ (pharmacist), 2+ with additional training, and naloxone access provisions.

How do I register for the NY MPJE?

Register through NABP at nabp.pharmacy. Create an e-Profile, apply for the NY MPJE, pay fees ($100 application + $150 exam), and schedule at a Pearson VUE center.

What happens if I fail the NY MPJE?

You must wait at least 30 days before retaking. Reapplication and fees are required for each attempt.

How long should I study for the NY MPJE?

Most candidates study 2-4 weeks. Focus on Article 137 of the Education Law and Title 8 NYCRR, federal law, and scenario-based practice questions.

Does New York require EPCS?

New York mandates electronic prescribing for controlled substances. E-prescriptions must comply with DEA EPCS requirements under 21 CFR Part 1311.